Skip to main content
Log in

Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

In an attempt to develop platinum-containing drugs for use with hyperthermia that would be relatively nontoxic at 37° C but would become very cytotoxic at 42° or 43° C, several nuclear dyes were complexed to the tetrachloroplatinum(II) dianion (PtCl4) at a ratio of 2:1. The cytotoxicity of PtCl4 complexes of three thiazin dyes (thionin, azure B, and methylene blue), the xanthene dye pyronin Y, and the thiazole dye thioflavin was examined in exponentially growing euoxic and hypoxic EMT6 cells in vitro at 37°, 42°, and 43° C and at pH 7.40 and 6.45. Of the thiazin dye complexes, the cytotoxicity of Pt(methylene blue)2 was most enhanced at hyperthermic temperatures. Both Pt(pyronin Y)2 and Pt(thioflavin)2 also became markedly more cytotoxic at 42° and 43° C at pH 6.45 vs pH 7.40. In vivo tumor excision assays in the FSaIIC fibrosarcoma showed that with each of the thiazin dye-platinum complexes, hyperthermia enhanced cell kill [most effectively on Pt(methylene blue)2] but was not dose-modifying. For both Pt(pyronin Y)2 and Pt(thioflavin)2, however, administration of 43° C, 30-min hyperthermia to the tumor immediately after i.p. drug injection was dose-modifying. Tumor growth delay studies in the FSaIIC tumor system demonstrated that, as with the in vitro studies, Pt(pyronin Y)2 and Pt(methylene blue)2 were most enhanced by hyperthermia [tumor growth delay increased by 4.8- and 3.0-fold, respectively, vs only 1.3-fold for cisplatin (CDDP)]. Examination of intracellular platinum levels after exposure of EMT6 cells to 25 µM of drug for 1 h at 37° and 42° C and at pH 7.40 and 6.45 showed that each platinum-dye complex achieved platinum levels that were 100–600 times higher at 37° C and pH 7.40 than those obtained using CDDP. The platinum levels for each drug dropped markedly when exposure took place at pH 6.45. Exposure at 42°C only moderately increased platinum levels in cells exposed to these drugs. Thus, for several of these drugs the level of cytotoxicity observed was in great part independent of the intracellular platinum levels achieved. Pt(pyronin Y)2 is an effective drug for use with hyperthermia, and further studies using this combination with and without radiation are under way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abrams MJ, Picker DH, Fackler PH, Lock CJL, Howard-Lock HE, Faggiani R, Teicher BA, Richmond RC (1986) The synthesis and structure of [(rhodamine 123)2PtCl4] · 4H2O: the first tetrachloroplatinate(II) salt with anti-cancer activity. Inorg Chem 25: 3980

    Article  CAS  Google Scholar 

  2. Drummer OH, Proudfoot A, Howes L, Louis WJ (1984) High-performance liquid chromatography determination of platinum(II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrophotometric method. Clin Chim Acta 136: 65

    Article  PubMed  CAS  Google Scholar 

  3. Gerner EW, Holmes PW, McCullough JA (1979) Influence of growth state on several thermal responses of EMT6/Az tumor cells in vitro. Cancer Res 39: 981

    PubMed  CAS  Google Scholar 

  4. Gerweck LE (1977) Modification of cell lethality at elevated temperatures: the pH effect. Radiat Res 70: 224

    Article  PubMed  CAS  Google Scholar 

  5. Herman TS, Teicher BA (1988) Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Res 48: 2693

    PubMed  CAS  Google Scholar 

  6. Herman TS, Sweets CC, White DM, Gerner EW (1982) Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst 68: 487

    PubMed  CAS  Google Scholar 

  7. Herman TS, Teicher BA, Cathcart KNS, Kaufmann ME, Lee JB, Lee M (1988) Effect of hyperthermia oncis-diamminedichloroplatinum(II) and Pt(Rh-123)2 in a human squamous carcinoma cell line and acis-diamminedichloroplatinum(II) resistant subline. Cancer Res 48: 5101

    PubMed  CAS  Google Scholar 

  8. Herman TS, Teicher BA, Chan V, Collins LS, Kaufmann ME, Loh C (1988) The effect of hyperthermia on the action ofcis-diamminedichloroplatinum(II),rhodamine-1232[tetrachloroplatinum(II)], rhodamine-123 and potassium tetrachloroplatinum in vitro and in vivo. Cancer Res 48: 2335

    PubMed  CAS  Google Scholar 

  9. Herman TS, Teicher BA, Jochelson M, Clark J, Svensson G, Coleman CN (1988) Rationale for the use of hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 4: 143

    Article  PubMed  CAS  Google Scholar 

  10. Herman TS, Jochelson MS, Teicher BA, Scott PJ, Hansen J, Clark JR, Gelwan LE, Molnar-Griffin BJ, Fraser SM, Svennson G, Bornstein BA, Coleman CN (1989) A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys 17: 1273

    PubMed  CAS  Google Scholar 

  11. Rice L, Urano M, Suit HD (1980) The radiosensitivity of a murine fibrosarcoma as measured by three cell survival assays. Br J Cancer 41 [Suppl 4]: 240

    Google Scholar 

  12. Rockwell S (1977) In vivo-in vitro tumor systems: new models for studying the response of tumors to therapy. Lab Anim Sci 27: 831

    PubMed  CAS  Google Scholar 

  13. Rockwell S (1978) Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumor cells in vivo and in vitro. Br J Cancer 37: 212

    CAS  Google Scholar 

  14. Rockwell S, Kallman RF (1973) Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res 53: 281

    Article  PubMed  CAS  Google Scholar 

  15. Rockwell SC, Kallman RF, Fajardo LF (1972) Characteristics of serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 49: 735

    PubMed  CAS  Google Scholar 

  16. Teicher BA, Holden SA (1987) Antitumor and radiosensitizing activity of several platinum-positively charged dye complexes. Radiat Res 109: 58

    Article  PubMed  CAS  Google Scholar 

  17. Teicher BA, Rose CM (1984) Perfluorochemical emulsion can increase tumor radiosensitivity. Science 223: 934

    Article  PubMed  CAS  Google Scholar 

  18. Teicher BA, Lazo JS, Sartorelli AC (1981) Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73

    PubMed  CAS  Google Scholar 

  19. Teicher BA, Rockwell S, Lee JB (1985) Radiosensitivity by nitroaromatic Pt(II) complexes. Int J Radiat Oncol Biol Phys 11: 937

    PubMed  CAS  Google Scholar 

  20. Teicher BA, Holden SA, Cathcart KNS (1987) Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X-rays. Int J Radiat Oncol Biol Phys 13: 1217

    PubMed  CAS  Google Scholar 

  21. Teicher BA, Herman TS, Kaufmann ME (1989) PtCl4(Nile blue)2 and PtCl4(neutral red)2: DNA interaction, cytotoxicity and radiosensitization. Radiat Res 120: 129

    Article  PubMed  CAS  Google Scholar 

  22. Teicher BA, Herman TS, Kaufmann ME (1989) Interaction of PtCl4(fast black)2 with superhelical DNA and with radiation in vitro and in vivo. Radiat Res 119: 134

    Article  PubMed  CAS  Google Scholar 

  23. Teicher BA, Herman TS, Kaufmann ME (1989) Platinum complexes of triaminotriphenylmethanes: interaction with DNA and radiosensitization. Cancer Lett 47: 217

    Article  PubMed  CAS  Google Scholar 

  24. Teicher BA, Herman TS, Kaufmann ME (1989) Cytotoxicity, radiosensitization and DNA interaction of platinum complexes of thiazin and xanthene dyes. Radiat Res 121: 187

    Article  Google Scholar 

  25. Vaupel P, Frinak S, Bicher HI (1981) Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocracinoma. Cancer Res 41: 2008

    PubMed  CAS  Google Scholar 

  26. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F (1987) Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res 47: 3496

    PubMed  CAS  Google Scholar 

  27. Wang H, Shah V, Lanks KW (1987) Use of oxidizing dyes in combination with 2-cyanocinnamic acid to enhance hyperthermic cytotoxicity in L929 cells. Cancer Res 47: 3341

    PubMed  CAS  Google Scholar 

  28. Wang Y, Herman TS, Teicher BA (1988) Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment. Br J Cancer 59: 722

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported by NCI grants ROI-CA47379 and ROI-CA36508

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herman, T.S., Teicher, B.A., Raphael Pfeffer, M. et al. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia. Cancer Chemother Pharmacol 26, 127–134 (1990). https://doi.org/10.1007/BF02897258

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02897258

Keywords

Navigation